18 May 2013
Keywords: fda, accepts, fusilev, snda, mcrc, usa, spectrum
Article | 27 March 2009
The USA's Spectrum Pharmaceuticals says the Food and Drug Administration has accepted for filing and review the supplemental New Drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 March 2009
30 March 2009
17 May 2013
© 2013 thepharmaletter.com